Global Biologics Drug Development Market Size, Status and Forecast 2019-2025

SKU ID : QYR- 12993446

Publishing Date : 17-Jan-2019

No. of pages : 99

PRICE
3900
7800


  • Biologics are defined as pharmaceutical products obtained from living cells or microorganisms.
    In 2018, the global Biologics Drug Development market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025.

    This report focuses on the global Biologics Drug Development status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Biologics Drug Development development in United States, Europe and China.

    The key players covered in this study
    Abbvie
    Allergan
    Boehringer Ingelheim
    Charles River Laboratories
    Catalent
    Lonza Group
    Amgen
    Sanofi

    Market segment by Type, the product can be split into
    Clinical Manufacturing
    Formulation Development
    Bioassay Development
    Analytical Services

    Market segment by Application, split into
    In-House
    Outsource
    Pharma Excess

    Market segment by Regions/Countries, this report covers
    United States
    Europe
    China
    Japan
    Southeast Asia
    India
    Central & South America

    The study objectives of this report are:
    To analyze global Biologics Drug Development status, future forecast, growth opportunity, key market and key players.
    To present the Biologics Drug Development development in United States, Europe and China.
    To strategically profile the key players and comprehensively analyze their development plan and strategies.
    To define, describe and forecast the market by product type, market and key regions.

    In this study, the years considered to estimate the market size of Biologics Drug Development are as follows:
    History Year: 2014-2018
    Base Year: 2018
    Estimated Year: 2019
    Forecast Year 2019 to 2025
    For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.